Find an expert

Chiara is Professor in Veterinary Pathology at the School of Veterinary Science (SVS) of the University of Queensland (UQ). She is a board certified specialist veterinary pathologist (Diplomate of the European College of Veterinary Pathology), graduated with a DVM from the University of Teramo (Italy) in 2002 and a PhD in Ultrastructural Pathology in 2006. Before joining UQ in 2012, she has been working as an Assistant Professor in Veterinary Pathology at the University of Teramo (Italy). She has a specific research interest is small animal oncology, in particular canine prostate cancer, and veterinary oncoepidemiology. She is Chair of the canine prostate cancer subgroup at the Oncology Pathology Working Group (OPWG), co-coordinator of the Global Initiative for Veterinary Cancer Surveillance (GIVCS) committee for the establishment of international standards of veterinary cancer registration and team leader of the comparative oncology theme of the Queensland Alliance of One Health Science. She is also member of the board of the Veterinary Cancer Guidelines and Protocols (VCGP) group, member of the Oncology Committee of the World Small Animal Veterinary Association (WSAVA) and chair of the ESVP/ECVP DEI task force. She is past President of the Australian Society for Veterinary Pathology and, within UQ SVS, she has been postgraduate coursework coordinator (2014-2017), HDR coordinator (2017-2019) and Director of Research (2019-2021). She is now coordinator of the UQ SVS veterinary pathology postgraduate training program. She has received several academic awards, including SVS awards for research excellence (2017, 2021), best lecturer (2021, 2022, 2023, 2024), and UQ award for excellence in HDR supervision (2020). She has published more than 120 papers on international journals, 3 book chapters and numerous abstracts in proceedings of national and international conferences. She has > 15 years expertise in veterinary diagnostic pathology, histopathology, IHC and TEM in multiple species. Since her first academic appointment in 2005, she mentored several postgraduate and undergraduate students in diagnostic investigation of animal cancer and research in canine oncology. Although outside the field of comparative oncology, she also a unique expertise in avian pathology and transmission electron microscopy.

Career Summary: 2009: PhD, University of Michigan, USA with training in cardiac physiology, modelling myocardial ischemia in vivo and in vitro, and development of therapeutic approaches for myocardial ischemia; 2009–2015: Postdoctoral Research Fellow, University of Washington, Institute for Stem Cell and Regenerative Medicine, USA with training in stem cell biology, genomics, genome editing, and cell therapeutics for ischemic heart disease; 2015–current: Group Leader, University of Queensland (UQ), Institute for Molecular Bioscience; 2022-current: Associate Professor, UQ; 2018–2021 and 2023-2026: National Heart Foundation Future Leader Fellow. Dr. Palpant’s research team has expertise in human stem cell biology, computational genomics, and cardiac physiology, which enables them to translate outcomes from cell biology and genomics to disease modelling, drug discovery, and preclinical modelling.

Prof Ben Panizza is the Chairman of Otolaryngology - Head and Neck Surgery for Metro South and Director of the Queensland Head and Neck Cancer Centre. He has been active in head and neck cancer management for 27 years. He has created innovative approaches in dealing with malignancies extending to the skull base one of the most anatomically complex regions of the body. He is recognised as a world leader in cutaneous malignancy extending to the temporal bone and perineurial spread of keratinocyte skin cancers, being regularly invited overseas to present. Prof Panizza is active in integrating new treatments with surgery to change treatment paradigms and improve outcomes for patients. He is a professor in the Faculty of Medicine at the University of Queensland and works collaboratively with basic scientist and has supervised to completion 28 research higher degrees over the last 12 years. He has established an in department clinical trials unit to run clinical trials from proof of principle to phase 3 clinical trials enabling access and rapid translation for his scientific partners at the Princess Alexandra Hospital which has one of Australia's largest head and neck clinics. Prof Panizza is a clinical consultant and advisor to industry (Merck, Sanofi, QBiotics, Decibel Therapeutics) and sits on the governing bodies of both the International Federation of Head and Neck Oncological Societies and The World Federation of Skull Base Societies. He has been the President of the Australian and New Zealand Head and Neck Cancer Society and was the Foundation president of the Australian and New Zealand Skull Base Society. He is active in publishing and sits on the editorial boards of the major head and neck journals (Head Neck, Oral Oncology, Skull Base, ANZ Journal of Surgery).

Dr Kerstin Pannek joined UQ’s School of Electrical Engineering and Computer Science in 2023. Her research program utilises neonatal and pediatric brain MRI to gain insights into normal and abnormal brain development, predict neurodevelopmental outcomes of at-risk infants such as those born very preterm or with fetal growth restriction, and identify brain plasticity in response to intervention in children with cerebral palsy.

Her research expertise is in advanced diffusion MRI and structural connectivity analysis.

I am a passionate neuroscientist, working as a Postdoctoral Researcher at the School of Biomedical Sciences (SBMS, UQ).

I have always had a deep interest in Medicine and Biology, which brought me to first successfully complete a bachelor degree in Medicine and Surgery in 2013 (University of Insubria, Italy), and then a PhD in Neuroscience in 2019 (Queensland Brain Institute, QBI, UQ). My PhD investigated how the connections of the cerebral cortex develop and evolve in different animal species, with a specific focus on the plasticity of these connections in health and disease.

During my first Postdoctoral experience in the laboratories of Dr Opazo and A/Prof Anggono (QBI, UQ), I worked on a project involving cutting-edge live-cell imaging using a two-photon microscope to investigate how key molecules are distributed in the brain during neuronal plasticity, both in vitro and in vivo, followed by behavioural assays.

Thanks to this experience, I gained unique surgical, behavioural, and imaging expertise that I am now employing to answer questions of brain evolution and development in the laboratories of Dr Fenlon and A/Prof Suárez at SBMS. In my current position I am investigating how the different timing (heterochrony) of developmental processes in brain development can cause dramatic changes in the final brain structure, both in the context of evolution as well as disease.

Chris has a passion for optimising care for people experiencing pain after traumatic injury, as a researcher and clinician; Research Fellow in musculoskeletal injury at the RECOVER Injury Research Centre and an Exercise Physiologist (ESSA) with 10 years of clinical experience in rehabilitation hospital settings. He co-leads the 'Knowledge translation, education and implementation' theme for the Centre for Innovation in Pain and Health Research (CIPHeR); CIPHeR unites groups of pain researchers across The University of Queensland to work collaboratively toward the single end of cracking the code on pain. Chris' is primarily involved in translation and implementation science projects centred on the management of musculoskeletal pain conditions, including: implementing key recommendations from the Australian whiplash clinical guidelines with health professionals and insurers; upskilling physiotherapists in delivering integrated psychological and physical care for people after road traffic injury; and developing international clinical guidelines for chronic non-specific neck pain.

Zoe is a Honorary Research Fellow with the School of Human Movement and Nutrition Sciences. She also currently holds an appointment as a Senior Research Officer with the Mental Health Evaluation Research Stream at Queensland Centre for Mental Health Research (QCMHR), where she leads and manages large-scale evaluation projects that seek to enhance mental health services within Queensland. During her time at QCMHR, she has worked on several state-wide evaluations for Queensland Health - including of their Crisis Support Spaces, Adolescent Day Program and Youth and Adult Step-Up-Step-Down Programs.

Zoe's research work largely focuses on the development, implementation and evaluation of interventions that seek to promote positive health behaviours and which improve social and mental health outcomes. Previously, she developed and trialled a behavioural support program (Active Choices) for the Department of Veterans Affairs, with the aim of increasing self-managed physical activity and social connectedness in Australian Defence Force veterans. Zoe has also designed and evaluated a brief motivational intervention for cannabis users (iAx), which is now in routine use at the Princess Alexandra Hospital.

In addition to her work as a researcher, Zoe has held roles in health consulting where she assisted State and Federal Government agencies, PHNs and peak bodies to design, implement and review health services, programs and policies.

Zoe's educational background in psychology, having completed a Bachelor of Psychological Science (2013) and Doctor of Philosophy (2020) in this discipline.

Ravi Pappu is an Associate Professor of Marketing at the UQ Business School, University of Queensland, Australia. He teaches topics related to applying quantitative research methods in business to honours and PhD students and market and consumer research to postgraduate students.

Over the years, he has received the UQ Business School Teaching Excellence Award and the UQ Business School Research Excellence Award. Twice he was a Finalist for a UQ Teaching Excellence award.

Ravi received a PhD in marketing from the University of New England, Australia, and an MBA and a Postgraduate Diploma in Marketing, both awarded with Distinction from the University of Waikato, New Zealand. Earlier, he received a Bachelor’s degree in Mechanical engineering from JNTU, Anantapur in India, awarded with First Class and Distinction.

Ravi's research interests include the areas of advertising, branding, international marketing, new products and innovation. His research has been published in several internationally recognised journals, including the Journal of International Business Studies and the Journal of the Academy of the Marketing Science. His research has been funded through several competitive grants, including ARC.

Ravi serves on the editorial review boards of premier international journals, including the Journal of International Marketing, the Journal of Business Research and the European Journal of Marketing. He is a member of the American Marketing Association (AMA) and Society for Consumer Psychology (SCP), a Fellow of the Academy of the Marketing Science (AMS) and a Fellow CPM of the Australian Marketing Institute (AMI).

Further information about Ravi is available at the following links.

|Facebook | LinkedIn | ResearchGate | Google Scholar | UQ Researchers | Publons |

RESEARCH

Ravi's current research focuses on modelling consumer decision-making concerning different types of brands (e.g. manufacturers, retailers, nonprofits and countries). He is also interested in understanding how marketing communications (e.g. advertising, celebrity endorsement, sponsorship) can shape consumer attitudes and brand perceptions.

Ravi's research on sponsorship, brand equity, brand innovativeness, country-of-origin effects, celebrity endorsement, country branding and retailer branding has been published in scholarly international journals, including. His research papers have been read or downloaded over 370,000 times.

|Journal of the Academy of Marketing Science | Journal of Business Research | International Business Review | Journal of International Business Studies | European Journal of Marketing | Journal of Retailing and Consumer Services | Journal of Marketing Education | Journal of Public Policy and Marketing | Journal of Product and Brand Management | Journal of Travel Research |

Research Grants

Ravi was the lead Chief Investigator of an Australian Research Council Linkage project (with Bettina Cornwell) supported by the Australian Red Cross Blood Service. Major outcomes of this research include a model for explaining communication portfolio effects on the image and equity of non-profit brands. Ravi's research has also attracted several internal competitive grants from the University of New England and the University of Queensland.

Awards & Distinctions

• 2018 - Inaugural JPBM Award for most impactful article, Emerald Literati Network (with P.G. Quester & R.W. Cooksey)
• 2016 - Outstanding Reviewer of the Year Award, Emerald Literati Network
• 2015 - UQ Business School Teaching Excellence Award
• 2009 - Outstanding Reviewer of the Year Award, Emerald Literati Network
• 2006 - UQ Business School Research Excellence Award
• 2000 - Best Marketing Research Paper Award, American Marketing Association (with A. Sinha & P. Leszeczyc)
• 1998 - Highly Commended Paper, Doctoral Colloquium, Australian and New Zealand Marketing Academy Conference

TEACHING

As of 2024, Ravi teaches courses in quantitative research methods and applied statistics.

• RBUS6902 Quantitative Business Research Methods I

Distinctions (Teaching)

• 2015 - UQ Business School Teaching Excellence Award
• 2015 - Finalist - University of Queensland Teaching Excellence Award
• 2014 - Finalist - University of Queensland Teaching Excellence Award

Teaching Evaluations (Click on the following links to view student evaluations in pdf)

Honours/PhD

• RBUS6903 Quantitative Business Research Methods II (SEM) |2020 | 2019 | 2015 | 2014 | 2013 |
• RBUS6902 Quantitative Business Research Methods I (Multivariate Analysis) | 2024 (s2) | 2024 (s1) | 2023 (S2) | 2023 (s1) | 2022 (s2) |2022 (s1) |2021 |2020 | 2019 | 2018 |2017| | 2016 |
• RBUS6931 Scientific Method in Management II | 2018 |2015 | 2014 | 2013 | 2012 |
• RBUS6931 Scientific Method in Management I | 2018 |2017|

Postgraduate

• MKTG7510 Market and Consumer Research |2019 | 2018 |2017| | 2016 | 2015 |

PhD Supervision

Ravi is available for research supervision. His previous research students have achieved publications in internationally recognised journals (e.g., European Journal of Marketing, Journal of Business Research and Journal of Travel Research) and conferences (e.g., AMA, AMS, WMC). Following are some of the areas of his research interest.

| Brand equity | Brand innovativeness | Celebrity endorsement | Corporate sponsorship | Country-of-origin effects |

PhD

• W. Sun (2023) - Tourist misbehaviour (Associate)
• S. Saha (2022) - Corporate giving
• M. Hassan (2022) - New product preannouncement
• M. Chien (2009) - Corporate sponsorship

Honours

| Maddy Nugent (2022) - Sponsorship authenticity | B.D.C. Tang (2021) - Sponsorship engagement | M.G. Guerra Calvo (2020) - Celebrity endorsement | S. Caulton (2019) - Brand crises | I. Goh (2018) - Sponsorship portfolios | I. C. Y. Lim (2016) - Brand innovativeness | S.C. Yu (2013) - Celebrity portfolios | A. Spry (2007) - Celebrity endorsement | M. Chong (2006) - Consumer innovativeness | P. Stower (2006) - Multiple celebrity endorsement |

SERVICE

Associate Editor

• International Journal of Consumer Studies (2020 - 2024)

Co-Guest-Editor

• Journal of Strategic Marketing - Special issue on Research in Strategic Marketing
• Journal of Product & Brand Management - Special issue on Brand Equity

Editorial Board Membership

| Journal of International Marketing | Journal of Business Research | European Journal of Marketing | International Marketing Review | Asia Pacific Journal of Marketing and Logistics | Australasian Marketing Journal |

Assessor

• Australian Research Council

Invited Seminars

| Australian National University | IIM-Calcutta | IIM-Ahmedabad | Indian Institute of Science | IIM - Bangalore | University of Melbourne | University of New South Wales | University of Adelaide | University of New England |

Visiting Positions

| Indian Institute of Management - Bangalore 2016 | University of Oregon 2013 | University of Adelaide 2009 | University of Michigan 2009 | Indian School of Business 2003 |

Marie-Odile Parat (MO) joined the School of Pharmacy as Senior Lecturer in December 2007.

MO obtained her Pharm.D. from University Joseph Fourier in Grenoble, France, a Masters in Cutaneous Biology from University Claude Bernard in Lyon, France and her Ph.D. in Cell Biology from University Joseph Fourier in Grenoble, France. She further has post graduate diplomas in the fields of Biomedical and Industrial Pharmacy, Photobiology, Pharmaceutical Management, and Public Health.

MO did her Pharmaceutical Residency at the University Hospitals of Grenoble, France in the Sterile Pharmaceutical Supplies Headquarters, the Department of Nuclear Medicine, and the Laboratory Medicine Department of Biochemistry. Attracted by international working experience, she carried out research within the R&D laboratories of Estee Lauder in Melville, NY. She further worked for the United Nations International Trade center in Geneva, Switzerland, where she was the Product Specialist on market information for pharmaceutical raw materials/essential drugs for three years in collaboration with the World Health Organization.

She later performed post-doctoral research in the Universidade de São Paulo, SP, Brasil and The Cleveland Clinic Foundation in the United States. She was appointed as a Staff Scientist in the Center for Anesthesiology Research of the Cleveland Clinic in 2003, an Assistant Professor of Molecular Medicine in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, and a Member of the Case Cancer Center.

During her research career MO has attracted awards from various funding agencies including the Research Funding Agency of the State of São Paulo (FAPESP), the American Heart Association, the Ohio Cancer Research Associates, the American Cancer Society, the National Heart Foundation of Australia, Cancer Council Queensland, Australian and New Zealand College of Anaesthetists and the Australia Research Council (ARC).

The long term goal of the Parat laboratory is to provide insight for novel cancer therapies. A basic science team focusses on endothelial and cancer cell migration, invasion, angiogenesis, and specialized plasma membrane subdomains termed caveolae. A translational axis of research evaluates novel mechanisms by which opioids administered to cancer patients modulate the risk of long term tumour recurrence and metastasis.

Associate Professor Parbhakar-Fox is a Principal Research Fellow in Mine Waste Geoscience at the W.H Bryan Mining and Geology Research Centre within the Sustainable Minerals Institute. She is the founding leader of Australia's premier secondary prospectivity research group- Mine Waste Transformation through Characterisation (MIWATCH). Associate Professor Parbhakar-Fox is also a deputy director in the Critical Resources for the Future ARC ITTC (collaborating with UWA, ANU and UoA).

Associate Professor Parbhakar-Fox's research is focussed on mine waste characterisation to improve mine planning and waste management practices. , Associate Professor Parbhakar-Fox has worked with mining industry, METS sector and government stakeholders. Associate Professor Parbhakar-Fox has developed new tests and protocols for improving waste characterisation and has led projects looking for innovative solutions to remediate abandoned/ historical mine sites. Most recently, Associate Professor Parbhakar-Fox has led major government and industry funded projects characterising a range of mine waste materials to evaluate their economic potential in the context of critical metals.

Before completing her PhD in 2012 at the Centre for Ore Deposit and Earth Sciences (CODES), Anita obtained a 1st class MSc (Hons) degree from the Royal School of Mines, Imperial College (University of London) in Environmental Geology (2005). Professionally, she has worked as an environmental consultant (2005-06) and as a research assistant for the AMIRA P843 geometallurgy project (2006-07). She worked part-time as a Junior Research Fellow for the Cooperative Research Centre for Optimising Resource Extraction (CRC ORE; 2011-2012) and then went on to become a postdoctoral research fellow in the Environmental Indicators program (2012-2015). Next, Anita was appointed as a postdoctoral research fellow for the ARC TMVC Research Hub (2015-2019) where she serves as the deputy leader of Theme 3 (minimising geoenvironmental risks) and the leader (2016-2018) of Program 2 (Geometallurgy, Geoenvironment and Mining) at CODES.

Harendra's research interests are in the area of synthetic pharmaceutical chemistry, pharmaceutics as applied to nano-carriers, and advanced non-viral drug/gene delivery system design, synthesis and evaluation. His team at PACE have been instrumental in developing highly versatile micro- & nanobubble formulations, which when used in-conjuction with ultrasound, pave the way for improved rates of 'on-demand' drug delivery and release in target tissue. Harendra also has a keen interest in developing bioresponsive drug/gene delivery systems with current engagement with pharma partners, globally, to commercialise his platforms. Separately, Dr Parekh has been developing a program to reformulate TCMs, in collaboration with researchers at a leading Chinese research institute; the outcomes of this work was aired across Asia in a BBC World News story, and showcased (TV & radio) by the Australian Academy of Science, National Touring Series.

BScPharm(Hon I), PhD (Nottingham)

Harendra completed his BSc in pharmacy (UK) and registered as a Pharmacist in 1998. He went onto undertake his PhD in Medicinal Chemistry at the University of Nottingham in the same year. Under the supervision of Dr B. Kellam and Dr. S. R. Chhabra he investigated the development of novel linkers for solid phase peptide and glycopeptide synthesis. Harendra was awarded his PhD in 2002, and after a short time working in community pharmacy in the UK relocated to Australia and took up a position as research officer in the School of Chemistry at UQ. He continues to be a member of the Royal Pharmaceutical Society of GB and is also registered with the AHPRA (pharmacist) in QLD.

During his post-doctoral tenure he explored the area of non-viral gene delivery via chemical synthesis of novel dendrimeric systems. Emphasis was on the treatment of age-related macular degeneration and in 2004 he received Uniquest's Trailblazer Prize for commercialisation potential. In May 2005 Dr Parekh was appointed Lecturer within the School of Pharmacy, and promoted to Senior Lecturer in 2011. He also holds adjunct positions at Manipal University (India), and the National University of Singapore's Nanoscience and Nanotechnology Institute (NNI).

Rachel Parker's research field is technology innovation systems and she has a discipline background in policy, governance and strategy.

Rachel has twenty years experience in higher education research leadership as Director Higher Degree Research Studies (UQ, 2003-2006), Associate Dean Research (QUT, 2009-2018), Dean Research Development (QUT 2014-2015), Director Centre for METS Business Innovation (QUT, 2017-2020) and most recently as Executive Director, Research Translation and Impact (UQ, 2022-2023). She has worked closely with State and Federal governments as an advisor on technology and innovation policy, research impact and university-industry research collaboration.

Rachel's research focuses on the business and social dimensions of uptake and diffusion of science and engineering research across the economy and the creation of new economic opportunities from new technologies. She was formerly Leader of the Industry Translation Capability and Chief Investigator of the ARC Centre of Excellence in Synthetic Biology, prior to taking up her current role. She was the inaugural Director Centre for Mining Equipment Technology and Services (METS) Business Innovation (QUT 2017-2020), funded by Queensland Government, Mining 3 and with major projects funded by CRCOre. She has led large-scale multi-disciplinary partnerships including ARC, CRC and commercial research. She has been a Lead Chief Investigator on three ARC Discovery Projects and a Chief Investigator on four ARC Linkage Projects and the Centre of Excellence in Creative Industries and Innovation.

Rachel was a member of the social sciences panel of the ARC Research Engagement and Impact assessment exercise, she was an invited expert witness before the Senate Economic References Committee inquiry into Australia’s innovation system, she was a member of the economic impact panel of the ATN/GO8 research impact assessment trial. Rachel has worked as an advisor on knowledge transfer activities for several public organisations and her leadership roles have involved the development of impact pathways including the coordination, design and delivery of collaborations with industry and government to maximise industry awareness of emerging industrial opportunities as well as the barriers and drivers of technology adoption and industry development.

Her publications appear in leading international journals in the field including Economic Geography, Sociology, Regional Studies, Industrial and Corporate Change, Environment and Planning A, Organization Studies, Entrepreneurship Theory and Practice and Work, Employment and Society. In addition to academic publications, her research on industrial innovation has been published in the Australia Higher Education Supplement and The Conversation. In 2005, Rachel received the UQ Vice Chancellor Foundation Research Excellence Award.